JY-207b

N/A

Report date: 2024/05/11 18:34:08

Base Information

Drug NameJY-207b

Drug Alias NameJY-207b

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Programmed death-ligand 1Anti-Cluster of differentiation 47

TargetsProgrammed death-ligand 1Cluster of differentiation 47

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesShenzhen Enduring Biotech Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Enduring Biotech Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A